Abstract
The in vitro antifungal activity of luliconazole, a novel topical imidazole, against pathogenic fungi implicated in dermatomycoses was studied. A total of 91 clinical isolates, consisting of 59 Trichophyton rubrum isolates, 26 T. mentagrophytes isolates, 1 Epidermophyton floccosum isolate, and 5 Candida albicans isolates were tested by the broth microdilution method, employing lanoconazole, terbinafine, and bifonazole as reference drugs. The minimum inhibitory concentrations (MICs) of luliconazole against T. rubrum and T. mentagrophytes were in the range of 0.00012–0.004 μg/ml and 0.00024–0.002 μg/ml, respectively. The MIC90 of luliconazole for these two species of dermatophytes was the same, at 0.001 μg/ml, and these values were 4 times, 30 times, and more than 1000 times lower than those of lanoconazole, terbinafine, and bifonazole, respectively. Similarly, the 1 isolate of E. floccosum tested was inhibited by luliconazole with an MIC of 0.001 μg/ml. Luliconazole also proved to be very potent against C. albicans (MIC range, 0.031–0.25 μg/ml), nearly on par, in terms of efficacy, with lanoconazole (0.063–0.25 μg/ml) and more potent than terbinafine (2–>64 μg/ml) and bifonazole (0.5–4 μg/ml). These results showed that luliconazole was very potent in vitro against pathogenic fungi isolated from patients with dermatomycoses, and these findings emphasized the utility of luliconazole for the topical management of this condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Y Niwano T Ohmi A Seo H Kodama K Kanai (2000) ArticleTitleLanoconazole and its relative compounds: progressive antifungal imidazole with a ketene dithioacetal structure Recent Res Devel Antimicrob Agents Chemother 4 81–102 Occurrence Handle1:CAS:528:DC%2BD3MXns1Gqs7Y%3D
Y Niwano N Kuzuhara H Kodama M Yoshida T Miyazaki H Yamaguchi (1998) ArticleTitleIn vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent Antimicrob Agents Chemother 42 967–70 Occurrence Handle9559824 Occurrence Handle1:CAS:528:DyaK1cXisFGmtLk%3D
K Uchida Y Nishiyama H Yamaguchi (2004) ArticleTitleIn vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent J Infect Chemother 10 216–9 Occurrence Handle15365862 Occurrence Handle1:CAS:528:DC%2BD2cXnsVCisL8%3D Occurrence Handle10.1007/s10156-004-0327-1
InstitutionalAuthorNameStandardization Committee of the Japanese Society of Medical Mycology (1999) ArticleTitleReport of the Standardization Committee of the apanese Society of Medical Mycology 1995–1997 Nippon Ishinkin Gakkai Zasshi 40 239–57
InstitutionalAuthorNameNational Committee for Clinical Laboratory Standards (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A NCCLS Wayne, PA 17(9)
InstitutionalAuthorNameNational Committee for Clinical Laboratory Standards (1998) Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed Standard M38-P NCCLS Wayne, PA 18(13)
InstitutionalAuthorNameNational Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A NCCLS Wayne, PA 22(16)
K Uchida H Yamaguchi (2004) ArticleTitleStatus and issues of preclinical evaluation of the therapeutic effects of newly developed antifungal agents Nippon Ishinkin Gakkai Zasshi 45 83–91 Occurrence Handle15118664 Occurrence Handle1:CAS:528:DC%2BD2cXlsF2hurk%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Koga, H., Tsuji, Y., Inoue, K. et al. In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses. J Infect Chemother 12, 163–165 (2006). https://doi.org/10.1007/s10156-006-0440-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10156-006-0440-4